RichardArandaMD

Chief Medical Officer, Gossamer Bio

Dr. Aranda is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Gastroenterology, 1992 - 1995
Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1986 - 1989
Stanford University School of MedicineClass of 1986

PubMed

210 citations
Mice with combined disruption of Gpx1 and Gpx2 genes have colitis.
R. Steven Esworthy, Richard Aranda, Martin G. Martin, James H. Doroshow, Scott W. Binder
American Journal of Physiology. Gastrointestinal and Liver Physiology. 2001-09-01
15 citations
Randomised clinical trial: a phase 1b study of GB004, an oral HIF-1α stabiliser, for treatment of ulcerative colitis.
Silvio Danese, Barrett G Levesque, Brian G Feagan, Alina Jucov, Bal Raj Bhandari
Alimentary Pharmacology & Therapeutics. 2022-02-01
12 citations
Challenges and Opportunities in IBD Clinical Trial Design
Marla Dubinsky, Rory Collins, Maria T. Abreu, Vipul Jairath, James D. Lewis
Gastroenterology. 2021-04-20

With GlaxoSmithKline in the Rearview Mirror, Abbas Hussain Is Ready to Lead a Biotech of His Own; Doug Treco Scores First CEO Job Since Ra Pharma BuyoutJune 25th, 2021
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing DealJune 22nd, 2021
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing DealJune 22nd, 2021
Join now to see all